A new approach to infusion of cardioplegic solutions in Cabrol technic
Horikoshi, S.
Kyobu Geka. Japanese Journal of Thoracic Surgery 40(11): 900-901
1987
ISSN/ISBN: 0021-5252 PMID: 3682463 Document Number: 286361
Document emailed within 1 workday
Related Documents
Takahashi, A.; Hearse, D.J.; Braimbridge, M.V.; Chambers, D.J. 1990: Harvesting hearts for long-term preservation. Detrimental effects of initial hypothermic infusion of cardioplegic solutions Journal of Thoracic and Cardiovascular Surgery 100(3): 371-378Silverman, N.A.; Wright, R.; Levitsky, S.; Schmitt, G.; Feinberg, H. 1985: Efficacy of crystalloid cardioplegic solutions in patients undergoing myocardial revascularization. Effect of infusion route and regional wall motion on preservation of adenine nucleotide stores Journal of Thoracic and Cardiovascular Surgery 89(1): 90-96
Menasche, P.; Groussett, C.; Piwnica, A. 1983: Ionic bases of cardioplegic solutions. II. Influence of the ionic composition of a cardioplegic solution on the metabolic and functional preservation of ischemic myocardium. Experimental evaluation with phosphorus 31 nuclear magnetic resonance and applications to cardiac surgery Archives des Maladies du Coeur et des Vaisseaux 76(12): 1465-1474
Yu, G.; Ye, D. 1990: Optimal potassium concentration in cardioplegic solutions Zhonghua Xin Xue Guan Bing Za Zhi 18(1): 42-6 62
Salerno, T.A.; Chiong, M.A. 1980: Cardioplegic arrest in pigs. Effects of glucose-containing solutions Journal of Thoracic and Cardiovascular Surgery 80(6): 929-933
Onishchenko, N.A.; Lubiako, A.A. 1985: Anti-ischemic protection of the myocardium by cardioplegic solutions Vestnik Akademii Meditsinskikh Nauk SSSR 1985(4): 40-47
D'Alessandro, L.C.; Cini, R.; Stazi, G.; Pucci, A.; De Benedictis, F.; Rabitti, G.; Benhar, M.; Giacopino, F.; Pezza, E.; Cioli, G. 1987: Creatine phosphate: an additive to cardioplegic solutions. Clinical study Cardiologia 32(3): 307-313
Pereira, S.N.; Ribeiro, C.T.; Raiser, A.G.; Tabone, E.J.; Andujar, M.B.; Marques, R.S. 1983: Myocardial protection in cardiac surgery. Comparison of 2 cardioplegic solutions Arquivos Brasileiros de Cardiologia 40(4): 255-258
Dias, R.R.; Stolf, N.A.G.; Dalva, M.; Dias, A.R.; Moreira, L.F.P.; Oliveira, S.A. 2004: Inclusion of lidocaine in cardioplegic solutions provides additional myocardial protection Journal of Cardiovascular Surgery 45(6): 551-555
Shikano, K.; Nasu, M.; Miyamura, K.; Sakai, T.; Shomura, S.; Kusagawa, M.; Hidaka, H. 1984: Experimental study on the effects of compositions of cardioplegic solutions on coronary arteries Nihon Kyobu Geka Gakkai 32(3): 294-300
Rousou, J.A.; Engelman, R.M.; Breyer, R.H.; Otani, H.; Lemeshow, S.; Das, D.K. 1988: The effect of temperature and hematocrit level of oxygenated cardioplegic solutions on myocardial preservation Journal of Thoracic and Cardiovascular Surgery 95(4): 625-630
Ishikura, Y.; Odagiri, S.; Shimazu, A.; Hirao, D.; Watanabe, H.; Hatooka, S.; Hamada, M. 1992: Clinical evaluation of myocardial protection by oxygenated crystalloid cardioplegic solutions with DBcAMP Nihon Geka Gakkai Zasshi 93(6): 632-638
Carrier, M.; Khalil, A.; Tourigny, A.; Solymoss, B.C.; Pelletier, L.C. 1996: Metabolic recovery after global myocardial ischemia: effects of blood cardioplegic solutions Canadian Journal of Cardiology 12(6): 607-611
Chong, Y.S.; Cottier, D.S.; Gavin, J.B. 1994: Myocardial protection during prolonged ischaemic cardiac arrest: experimental evaluation of three crystalloid cardioplegic solutions Journal of Cardiovascular Surgery 35(1): 35-44
Seydel, H.; Voigt, R. 1972: Stability of amino acid infusion solutions. 3. Influence of certain factors on the stability of amino acid infusion solutions Die Pharmazie 27(10): 660-669
Ferguson, T.B.; Smith, P.K.; Lofland, G.K.; Holman, W.L.; Helms, M.A.; Cox, J.L. 1986: The effects of cardioplegic potassium concentration and myocardial temperature on electrical activity in the heart during elective cardioplegic arrest Journal of Thoracic and Cardiovascular Surgery 92(4): 755-765
Gøtzsche, L.S.; Pedersen, E.M. 1994: Dose-dependent cardiotoxic effect of amiodarone in cardioplegic solutions correlates with loss of dihydropyridine binding sites: in vitro evidence for a potentially lethal interaction with procaine Journal of Cardiovascular Pharmacology 23(1): 13-23
Meyer, K.H.; Bickel, H. 1977: Ensuring the sterility of infusion solutions Klinische Anasthesiologie und Intensivtherapie 14: 18-20
Buxeraud, J. 2000: The first step in the use of infusion solutions in bags Revue de l'Infirmiere 58: 37-38
Barteczko, I.; Halkiewicz, A.; Gabiga, H.; Janicki, S. 1988: Stability of procaine hydrochloride in infusion solutions Polski Tygodnik Lekarski 43(24): 779-781